PACS Group, Inc.Raised 2026 revenue guidance and reported strong Q2 results.

PACS Group raised its full-year 2026 revenue guidance to a range of $5.75 billion to $5.85 billion, up from $5.65 billion to $5.75 billion, after reporting second-quarter revenue of $1,428 million and net income of $76.37 million. The company did not repurchase any shares through June 30, 2026, despite authorizing a buyback earlier in the year, suggesting management is prioritizing operating growth over returning capital via repurchases. The upgraded guidance supports the near-term growth catalyst around ramping newer facilities, but the main risk still centers on execution across a large, mixed-maturity portfolio and ongoing scrutiny of governance and compliance. Investors continue to weigh the guidance increase against policy risk in important Medicaid states and the aftermath of past investigations.
PACS Group, Inc.Raised 2026 revenue guidance and reported strong Q2 results.